Cargando…

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

BACKGROUND: Existing highly active antiretroviral therapy (HAART) effectively controls viral replication in human immunodeficiency virus type 1 (HIV-1) infected individuals but cannot completely eradicate the infection, at least in part due to the persistence of latently infected cells. One strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Leia K, Kobayashi, Yoshifumi, Chen, Chiann-Chyi, Russnak, Timothy A, Ron, Yacov, Dougherty, Joseph P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015732/ https://www.ncbi.nlm.nih.gov/pubmed/24156270 http://dx.doi.org/10.1186/1742-4690-10-120

Ejemplares similares

Histone deacetylase inhibitors containing a benzamide functional group and a pyridyl cap are preferentially effective human immunodeficiency virus-1 latency-reversing agents in primary resting CD4(+) T cells
por: Kobayashi, Yoshifumi, et al.
Publicado: (2017)

The switch between EBV latency and replication.
por: Miller, G.
Publicado: (1989)

Feline immunodeficiency virus latency
por: McDonnel, Samantha J, et al.
Publicado: (2013)

Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid
por: Krause, Christopher D, et al.
Publicado: (2011)

Development of chimeric and bifunctional antagonists for CLR/RAMP receptors
por: Chang, Chia Lin, et al.
Publicado: (2019)

Dynamic models of viral replication and latency
por: Mohammadi, Pejman, et al.
Publicado: (2015)

Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein
por: Wan, Zhitao, et al.
Publicado: (2014)

Recent developments in human immunodeficiency virus-1 latency research
por: Chan, Chi Ngai, et al.
Publicado: (2013)

Effects of Latency on Estimates of the COVID-19 Replication Number
por: Sadun, Lorenzo
Publicado: (2020)

Hypoxic microenvironment shapes HIV-1 replication and latency
por: Zhuang, Xiaodong, et al.
Publicado: (2020)

Human Immunodeficiency Virus (HIV)-1 Integration Sites in Viral Latency
por: Rezaei, Simin D., et al.
Publicado: (2015)

Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency
por: Wang, Zhuo, et al.
Publicado: (2017)

Inflammatory Monocytes Orchestrate Innate Antifungal Immunity in the Lung
por: Espinosa, Vanessa, et al.
Publicado: (2014)

CPI-637 as a Potential Bifunctional Latency-Reversing Agent That Targets Both the BRD4 and TIP60 Proteins
por: Zheng, Tengyi, et al.
Publicado: (2021)

CRABS CLAW Acts as a Bifunctional Transcription Factor in Flower Development
por: Gross, Thomas, et al.
Publicado: (2018)

Establishment of HSV1 Latency in Immunodeficient Mice Facilitates Efficient In Vivo Reactivation
por: Ramakrishna, Chandran, et al.
Publicado: (2015)

Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents
por: Delagrèverie, Héloïse M., et al.
Publicado: (2016)

Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure
por: Ventura, John D.
Publicado: (2020)

In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus
por: Schermuly, Julia, et al.
Publicado: (2015)

Sifting and Winnowing through Human Cytomegalovirus Lytic Replication and Latency
por: Kalejta, Robert F.
Publicado: (2016)

Host Restriction Factors Modulating HIV Latency and Replication in Macrophages
por: Pagani, Isabel, et al.
Publicado: (2022)

CXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis
por: Margulieux, Katie R., et al.
Publicado: (2016)

P300 Latency and Neurocognitive Functioning in Recently Diagnosed Human Immunodeficiency Virus Patients
por: Nehra, Ritu, et al.
Publicado: (2012)

The microRNA miR-29a is associated with human immunodeficiency virus latency
por: Patel, Paresh, et al.
Publicado: (2014)

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
por: Hayes, Alexander M.L.
Publicado: (2020)

Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells
por: Nehybová, Tereza, et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus Genome Replication, Partitioning, and Maintenance in Latency
por: Ohsaki, Eriko, et al.
Publicado: (2012)

Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency
por: Caviness, Katie, et al.
Publicado: (2016)

The role of miR-29a in HIV-1 replication and latency
por: Frattari, Giacomo, et al.
Publicado: (2017)

Strength of T cell signaling regulates HIV-1 replication and establishment of latency
por: Gagne, Matthew, et al.
Publicado: (2019)

Bifunctional Anti-Huntingtin Proteasome-Directed Intrabodies Mediate Efficient Degradation of Mutant Huntingtin Exon 1 Protein Fragments
por: Butler, David C., et al.
Publicado: (2011)

Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency
por: Li, Zichong, et al.
Publicado: (2019)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain
por: Lagard, Camille, et al.
Publicado: (2016)

Host signaling and EGR1 transcriptional control of human cytomegalovirus replication and latency
por: Buehler, Jason, et al.
Publicado: (2019)

HIV-1 replication and latency are balanced by mTOR-driven cell metabolism
por: Crater, Jacqueline M., et al.
Publicado: (2022)

Replication-dead gammaherpesvirus vaccine protects against acute replication, reactivation from latency, and lethal challenge in mice
por: Bland, Wesley A., et al.
Publicado: (2023)

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
por: Bobardt, Michael, et al.
Publicado: (2019)

Expression of the herpes simplex virus type 1 latency-associated transcripts does not influence latency establishment of virus mutants deficient for neuronal replication
por: Nicoll, M. P., et al.
Publicado: (2013)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
por: Wyllie, Susan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ltnln8gu4rvc6qp69bsmu6klhl